Table 4.
Comparison of our TSH reference intervals to previously published reference intervals (2.5, 50 and 97.5%) of different age groups.
Soldin et al., 1995 Abbott IMx® | Zurakowski et al., 1999 DELFIA® | Elmlinger et al., 2001 Immulite® | Djemli et al., 2004 Access 2® | Hübner et al., 2002 Advia Centaur® | Kapelari et al., Advia Centaur® | ||
Age | |||||||
TSH | [mU/L] | [mU/L] | [mU/L] | [mU/L] | [mU/L] | [mU/L] | |
n = 533 | n = 5,558 | n = 762 | n = 706 | n = 460 | n = 1,209 | ||
1 d – 7 d | F: 0.72 – 13.1 | n.d. | 1.79 – 4.63 – 9.69 | F: 1.5 – 3.3 – 6.5 | 0.13 – 9.23 a | 0.75 – 3.50 – 16.89 | |
8 d–15 d | M: 0.52 – 16.0 | n.d. | 1.80 – 3.71 – 7.97 | M: 0.7 – 2.4 – 9.8 | 0.16 – 8.48 b | ||
15 d – 1 m | n.d. | n.d. | |||||
1 – 12 m | 0.8 – 2.2 – 6.3 | F: 1.0 – 2.4 – 5.7 | 0.3 – 1.73 – 5.88 c | 1.30 – 2.85 – 7.09 | |||
1 – 2 y | 0.63 – 2.04 – 4.12 | M: 0.7 – 2.1 – 5.9 | |||||
2 – 3 y | F: 0.46 – 8.1 | F: 0.7 – 2.0 – 5.9 | n.d. | 0.42 – 1.98 – 4.79 | 1.00 – 2.70 – 5.42 | ||
3 – 4 y | M: 0.55 – 7.1 | M: 0.7 – 2.1 – 6.0 | n.d. | ||||
4 – 5 y | 0.53 – 1.60 – 2.94 | n.d. | |||||
5 – 6 y | F: 0.36 – 5.8 | n.d. | |||||
7 – 8 | M: 0.37 – 6.0 | F: 0.6 – 1.8 – 5.1 | 0.80 – 1.86 – 3.48 | n.d. | 0.48 – 1.87 – 4.67 | 0.90 – 2.30 – 4.40 | |
9 – 10 | M: 0.7 – 1.9 – 5.4 | 0.85 – 2.00 – 3.50 | F: 0.9 – 2.0 – 4.0 | ||||
M: 1.0 – 1.9 – 3.7 | |||||||
11 | 0.85 – 1.90 – 3.33 | ||||||
12 | F: 0.5 – 1.5 – 4.4 | 0.86 – 1.90 – 3.21 | F: 0.7 – 1.7 – 3.4 | 0.53 – 1.78 – 4.58 | 0.90 – 2.10 – 4.10 | ||
13 | M: 0.6 – 1.7 – 4.9 | 0.80 – 1.81 – 3.08 | M: 0.8 – 1.8 – 3.9 | ||||
14 | 0.76 – 1.70 – 2.83 | ||||||
15 | 0.70 – 1.56 – 2.55 | ||||||
16 | 0.64 – 1.54 – 2.51 | F: 0.6 – 1.5 – 3.7 | 0.56 – 2.00 – 4.53 | 0.70 – 1.70 – 3.93 | |||
17 | F: 0.5 – 1.3 – 3.9 | 0.62 – 1.51 – 2.42 | M: 0.7 – 1.4 – 2.8 | ||||
18 – 19 | M: 0.5 – 1.6 – 4.4 | 0.52 – 1.36 – 2.36 | n.d. |
a 1 d – 3 d
b 4 d – 30 d
c 61 d – 12 m